Immutep (IMMP) Deferred Taxes (2015 - 2016)

Immutep (IMMP) posted Deferred Taxes of -$884199.5 for Q2 2016, down 689.47% on a QoQ basis from -$111998.6 in Q2 2015, and down 689.47% year-over-year from $149998.2 in Q3 2015.

Immutep (IMMP) Deferred Taxes (2015 - 2016) Analysis & Trends

Immutep's Deferred Taxes history runs 2 years deep, the most recent figure standing at -$884199.5 for Q2 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -859,000.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -65.30 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 96.00 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Immutep 569.08 Mn 569.08 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2016 -884,199.45
Jun 30, 2015 -111,998.64